PROJECT 7. Free Radical
项目 7. 自由基
基本信息
- 批准号:8740616
- 负责人:
- 金额:$ 6.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-08 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAdvisory CommitteesAreaBioenergeticsBiologicalBiological AssayBiologyBuffersCancer BiologyCancer CenterCancer Center Support GrantCancer ControlCancer EtiologyCellular biologyChemotherapy-Oncologic ProcedureClinical ResearchClinical TrialsDetectionDevelopmentElectron Spin Resonance SpectroscopyEtiologyEvaluationFree RadicalsFreezingGenus HippocampusGrantInjuryInvestigationIonsKentuckyLipidsMalignant NeoplasmsManuscriptsMeasurementMeasuresMediatingMembraneMetabolismMetalsMethodologyMethodsMitochondriaModelingModificationMolecularMorphologic artifactsNeoplasm MetastasisNormal tissue morphologyNucleic AcidsOxidation-ReductionOxidative StressPreparationProteinsProteomicsReagentResearchResearch PersonnelResource SharingResourcesRoleSamplingServicesSignal TransductionStrategic PlanningSystemTechniquesTechnologyTherapeuticTrainingUniversitiesbiological systemscancer cellcancer preventioncancer therapycarcinogenesiscell injurychemotherapydrug discoveryinjury and repairinsightinstrumentationinterestmembermitochondrial dysfunctionnitrosative stressorganizational structureoxidative damagepre-clinicalprogramssample fixationtumor progression
项目摘要
There is increasing evidence that oxidative damage and free radicals, with sequelae of altered cellular energetics and protein alterations, are important in the initiation, promotion, invasion, metastasis, and treatment of cancers. Moreover, oxidative damage and free radicals also are implicated in the side effects of normal tissue injury following cancer therapy, including chemotherapy, radiafion, and biological modifiers. The Free Radical Biology in Cancer Shared Resource Facility (FRBC SRF) was established to provide expertise in and analyses of free radicals, cellular energetics, and reactive species, as well as proteomics in cancer and cancer biology for Markey Cancer Center (MCC) investigators who perform basic, pre-clinical, and clinical research. The four basic services provided by the FRBC SRF are: 1) Analysis of markers of oxidative and nitrosative stress; 2) Molecular biological manipulation of biological systems with which to investigate redox signals, including measurements of mitochondrial function by Seahorse technology; 3) Proteomics identification of differentially expressed, differentially oxidized, or differentially covalently modified proteins in various cancer-related systems; 4) Electron paramagnetic resonance (EPR) detection of free radicals. Development of new applications and methodology for better understanding of the roles of free radicals in cancer and cancer chemotherapy and technical assistance with grant and manuscript preparation by MCC investigators will also be provided. Included in these functions of the considerable expertise of the FRBC SRF Technical Advisory Committee to educate MCC investigators on proper sample handling and preparation methods so that reliable, precise, and artifact-free assay results are obtained. Multiple investigators from all four research programs of the MCC (Redox Injury and Repair [RR]; Cancer Cell Biology and Signaling [CS]; Cancer Prevention and Control [CP]; and Drug Discovery, Delivery and Translational Therapeutics [DT]) have used one or more services of the FRBC SRF. Indeed, even as a relatively new shared resource, the FRBC SRF still had usage by 26% of MCC investigators.
有越来越多的证据表明,氧化损伤和自由基具有改变细胞能量和蛋白质改变的后遗症,在起始,促进,侵袭,转移和癌症治疗中很重要。此外,氧化损伤和自由基也与癌症治疗后正常组织损伤的副作用有关,包括化学疗法,疗程和生物修饰剂。建立了癌症共享资源设施中的自由基生物学(FRBC SRF),以提供自由基,细胞能量和反应性物种的专业知识和分析,以及Markey Cancer Center(MCC)的癌症和癌症生物学中的蛋白质组学研究者(MCC)研究人员进行基本,临床前和临床研究。 FRBC SRF提供的四个基本服务是:1)分析氧化和亚硝化应激标记; 2)生物系统的分子生物操纵,以研究氧化还原信号,包括通过海马技术测量线粒体功能; 3)在各种癌症相关系统中,蛋白质组学鉴定差异表达,差异化或差异化修饰的蛋白质; 4)电子顺磁共振(EPR)检测自由基。还将提供新的应用和方法论,以更好地理解自由基在癌症和癌症化学疗法中的作用,以及MCC研究人员的赠款和手稿准备的技术援助。包括FRBC SRF技术咨询委员会的大量专业知识的这些职能中包括,以教育MCC调查人员有关适当的样品处理和准备方法,以便获得可靠,精确和无伪影的无分析结果。来自MCC的所有四个研究计划的多个研究人员(氧化还原损伤和修复[RR];癌细胞生物学和信号[CS];预防和对照[CP];以及药物发现,分娩和转化治疗[DT]) FRBC SRF的一项或多项服务。确实,即使是一种相对较新的共享资源,FRBC SRF仍然使用了26%的MCC调查人员使用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
D. Allan Butterfield其他文献
Electron spin resonance studies of an animal model of human congenital myotonia: Increased erythrocyte membrane fluidity in rats with 20,25-diazacholesterol-induced myotonia
人类先天性肌强直动物模型的电子自旋共振研究:20,25-二氮杂胆固醇诱导的肌强直大鼠红细胞膜流动性增加
- DOI:
10.1007/bf01905215 - 发表时间:
1977 - 期刊:
- 影响因子:0
- 作者:
D. Allan Butterfield;Wesley E. Watson - 通讯作者:
Wesley E. Watson
D. Allan Butterfield的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('D. Allan Butterfield', 18)}}的其他基金
mTOR activation and the pathogenesis of Alzheimer disease in Down syndrome
mTOR 激活与唐氏综合症阿尔茨海默病的发病机制
- 批准号:
9781860 - 财政年份:2018
- 资助金额:
$ 6.73万 - 项目类别:
Characterization of the Fidelity to PD of a Unique Rat Model
独特大鼠模型的 PD 保真度表征
- 批准号:
9129773 - 财政年份:2015
- 资助金额:
$ 6.73万 - 项目类别:
AD: OXIDATIVE STRESS,CALCIUM AND MITROCHONDRIAL DISORDER
AD:氧化应激、钙和线粒体紊乱
- 批准号:
6823626 - 财政年份:2004
- 资助金额:
$ 6.73万 - 项目类别:
BETA AMYLOID FREE RADICAL PRODUCTION AND NEUROTOXICITY--RELEVANCE TO AD
β 淀粉样蛋白自由基的产生和神经毒性——与 AD 的相关性
- 批准号:
6316460 - 财政年份:2000
- 资助金额:
$ 6.73万 - 项目类别:
BETA AMYLOID FREE RADICAL PRODUCTION AND NEUROTOXICITY--RELEVANCE TO AD
β 淀粉样蛋白自由基的产生和神经毒性——与 AD 的相关性
- 批准号:
6216947 - 财政年份:1999
- 资助金额:
$ 6.73万 - 项目类别:
BETA AMYLOID FREE RADICAL PRODUCTION AND NEUROTOXICITY--RELEVANCE TO AD
β 淀粉样蛋白自由基的产生和神经毒性——与 AD 的相关性
- 批准号:
6097996 - 财政年份:1999
- 资助金额:
$ 6.73万 - 项目类别:
BETA AMYLOID FREE RADICAL PRODUCTION AND NEUROTOXICITY--RELEVANCE TO AD
β 淀粉样蛋白自由基的产生和神经毒性——与 AD 的相关性
- 批准号:
6295317 - 财政年份:1998
- 资助金额:
$ 6.73万 - 项目类别:
BETA AMYLOID FREE RADICAL PRODUCTION AND NEUROTOXICITY--RELEVANCE TO AD
β 淀粉样蛋白自由基的产生和神经毒性——与 AD 的相关性
- 批准号:
6267237 - 财政年份:1998
- 资助金额:
$ 6.73万 - 项目类别:
相似国自然基金
基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
- 批准号:51009131
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
- 批准号:50178004
- 批准年份:2001
- 资助金额:23.0 万元
- 项目类别:面上项目
相似海外基金
Understanding the relationship between nurse staffing and outcomes: impact of individual nurse education, expertise, and effort level on individual patient outcomes
了解护士人员配置与结果之间的关系:护士个体教育、专业知识和努力水平对个体患者结果的影响
- 批准号:
10642570 - 财政年份:2023
- 资助金额:
$ 6.73万 - 项目类别:
Impact of the Gut Microbiome on Astrocyte Barrier Function
肠道微生物组对星形胶质细胞屏障功能的影响
- 批准号:
10723837 - 财政年份:2023
- 资助金额:
$ 6.73万 - 项目类别:
Incorporating Geriatric Constructs into Management of Inflammatory Bowel Diseases in Older Adults
将老年结构纳入老年人炎症性肠病的治疗
- 批准号:
10729893 - 财政年份:2023
- 资助金额:
$ 6.73万 - 项目类别:
Defining kinase interaction pathways to enhance anti-cancer efficacy and minimize associated morbidities of kinase inhibitor drugs.
定义激酶相互作用途径,以增强抗癌功效并最大限度地减少激酶抑制剂药物的相关发病率。
- 批准号:
10644554 - 财政年份:2023
- 资助金额:
$ 6.73万 - 项目类别:
Elucidation of mitochondrial mechanisms critical to mediating PFAS neurotoxicity
阐明对介导 PFAS 神经毒性至关重要的线粒体机制
- 批准号:
10805097 - 财政年份:2023
- 资助金额:
$ 6.73万 - 项目类别: